What is the prognosis for lip cancer?
Small, completely excised lower-lip squamous cell carcinomas have excellent control, with five-year survival commonly reported above 90%. Prognosis falls with large size, deep invasion, perineural spread, mandibular involvement, nodal metastasis and immunosuppression. Recurrence and new UV-related skin cancers are common enough that long-term skin surveillance is standard.
In detail
Published survival figures are population averages from registry data. Your own outlook depends on stage, HPV or EBV status, margins, nodal involvement, general health, smoking status during treatment and response to the first treatment.
Most recurrences occur within the first two to five years. Follow-up visits are frequent at first (every one to three months in year one) and become annual after year five, in line with NCCN survivorship guidance.
What this means in practice: this answer is part of the “Prognosis & follow-up” section of the Lip Cancer topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.
Other common questions about lip cancer
- What is lip cancer?Understanding the disease
- Where in the world is lip cancer most common?Understanding the disease
- What are the risk factors for lip cancer?Prevention & risk
- What are the early signs of lip cancer?Symptoms & diagnosis
- How is lip cancer diagnosed and staged?Symptoms & diagnosis
- What are the treatment options for lip cancer?Treatment
Sources for this answer
- NCCN Guidelines for Patients: Head and Neck Cancers
- Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022
- Trends of lip, oral cavity and oropharyngeal cancers in Australia 1982–2008
- Global Cancer Observatory (GLOBOCAN 2022)
- Ultraviolet radiation and skin cancer (fact sheet)
Need an opinion on your own case?
International patients can request a preliminary review based on pathology and imaging before travelling to China.
How the pathway works Send an enquiryMedical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.